1. Characters: White ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ, nke ukwuu hygroscopic.
2. Isi Iyi: Porcine eriri afọ mucosa.
3. Usoro: Heparin sodium na-amịpụtara si ike porcine eriri afọ mucosa.
4. Ngosipụta na ojiji: A na-ejikarị ngwaahịa a maka igbochi ọrịa thromboembolic, karịsịa maka mkpa nke anticoagulant ngwa ngwa, dị ka: 1. Nnukwu ma ọ bụ na-adịghị ala ala venous thrombosis ma ọ bụ enweghị ịrịba ọbara eruba dynamic mgbanwe nke pulmonary embolism (PE) .Heparin. nwere ike ịkwụsị ndọtị embolus iji wepụta oge maka thrombolysis nke anụ ahụ na-akpaghị aka.2. Mgbochi na ọgwụgwọ nke Atrial fibrillation na embolism.3. Ọgwụgwọ n'oge mgbasa intravascular coagulation (DIC).4. Mgbochi na ọgwụgwọ thrombosis mpụta ma ọ bụ myocardial infarction.5. Ndị ọzọ in vitro anticoagulation: dị ka ịwa ahụ obi, mgbasa ọbara in vitro, hemodialysis, angiography, nwekwara ike iji maka mmịnye ma ọ bụ nkwadebe ụdị ọbara, ugbu a isi ihe na-egosi ngwa ngwa heparin bụ thrombosis miri emi (DVT), PE na thrombosis. na nnukwu ihe ize ndụ ndị ọrịa.
· Gafere GMP nke China
· afọ 27 nke akụkọ ihe mere eme nke enzyme R&D
· A na-achọpụta ihe ọkụkụ
· Soro USP,EPna ọkọlọtọ ọkọlọtọ
· Mbupụ gaa na mba na mpaghara iri atọ
· Nwere ikike nke njikwa sistemụ dị mma dịka US FDA, Japan PMDA, South Korea MFDS, wdg.
Nnwale ihe | Nkọwapụta ụlọ ọrụ | ||
EP | USP | ||
Ndị agwa | White ma ọ bụ fọrọ nke nta ka ọ bụrụ ntụ ntụ, ukwuu hygroscopic | ||
njirimara | Thrombotest: kwekọrịtara | njirimara Chromatographic: kwekọrọ | |
1H NMR Spectrum: Dabara | 1H NMR Spectrum: Dabara | ||
Chromatography Liquid: Dabara | Arọ-nkezi arọ molekụla: 15000 ~ 19000 | ||
Sodium: dabara | Sodium: dabara | ||
Anti-factor Xa ka ihe mgbochi IIa ruru: 0.9 ~ 1.1 | Anti-factor Xa ka ihe mgbochi IIa ruru: 0.9 ~ 1.1 | ||
Nnwale | Ido anya na agba | Idozi: doro anya, Agba: site na 5 ma ọ bụ karịa | ———— |
Nitrogen | 1.5~2.5%(akọrọ ihe) | 1.3~2.5%(akọrọ ihe) | |
Nucleotidic adịghị ọcha | A2600.15 (4 mg / ml) | ≤ 0.1(w/w) | |
Ihe ndị metụtara ya | Dabara | ———— | |
Oke nke galactosamine na mkpokọta hexosamine | ———— | ≤ 1.0% | |
Chondroitin sulfate karịrị akarị | ———— | Dabara | |
pH | 5.5~8.0(1%) | 5.5~7.5(1%) | |
Ọnwụ na ihicha | ≤ 8.0%(60℃ kpọrọ nkụ na Vacuum, 3h) | ≤5.0%(60℃ kpọrọ nkụ na Vacuum, 3h) | |
Ihe fọdụrụ na mgbanye | ———— | 28.0%~41.0% | |
Ọgwụ nje endotoxin | ≤ 0.01 IU / Ngalaba Mba Nile nke Heparin | ≤ 0.03 USP U/Ngalaba Mba Nile nke Heparin | |
Igwe dị arọ | ≤30pm | ≤30pm | |
Sodium | 10.5~13.5%(akọrọ ihe) | ———— | |
Protein | ≤0.5%(akọrọ ihe) | ≤0.1%(Oke ibu) | |
Ihe omume | ≥ 180 IU/mg(akọrọ ihe) | ≥ 180 USP U/mg(akọrọ ihe) | |
Microbial adịghị ọcha | TAMC | ≤1000cfu/g | ≤1000cfu/g |
TYMC | ≤100cfu/g | ≤100cfu/g | |
E.coli | Dabara | Dabara | |
Staphylococcus aureus | Dabara | Dabara | |
Salmonella | Dabara | Dabara |